July 9th, 2024 How Medical Contact Centers Power Patient Recruitment for Clinical Trials Patient recruitment is one of the most critical and challenging aspects of clinical trials. Medical contact centers can be beneficial to the entire healthcare industry, but we’re going to focus on how they can help clinical trial participation. These contact centers drive study enrollment by improving the patient recruitment process through patient engagement and education. May 30th, 2024 3 in 4 surveyed patients show strong interest in replacing medications with both approved and experimental treatments. Over 131 million people in the US — roughly 66% of Americans — take prescription drugs regularly. That’s more than the number of people who watched the Super Bowl this year. And yet, 1 in 3 surveyed patients who take prescription medications said that they were unsatisfied with at least one of their current drugs. September 8th, 2023 Why HCP Outreach is so Important For Recruiting Patients in Rare Disease When it comes to recruiting patients for clinical trials in rare diseases, HCP outreach and support is essential. Most trials in the rare disease space struggle with patient recruitment unless they have a well thought out strategy on how to include HCPs in the recruitment process. December 7th, 2022 Compensation norms create inequity in clinical trials. Imagine a patient participating in a clinical trial for a new vaccine. They take a half day of PTO to visit the clinic, which is a short 15-minute drive from their home. After an hour visit, they are given $50 as compensation – a reasonable amount which they spend on a nice dinner. This describes November 8th, 2022 Secondary conditions and race/ethnicity affect type 2 diabetes patients’ interest in clinical trial participation. SubjectWell recently fielded a survey engaging over 300 type 2 diabetes patients. The findings showed that diabetes patients demonstrated high overall interest in clinical trial participation, but secondary conditions caused by their diabetes can shift that interest higher or lower. According to the CDC, more than 33 million Americans have type 2 diabetes. As patients’ September 8th, 2022 Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest. Minority populations are significantly underrepresented in clinical research. When comparing the FDA’s recent Drug Trial Snapshots data with US Census data, women, white patients, and older patients are shown to be overrepresented in clinical trials. Black patients make up just 8% and Hispanic patients 11% of trial participants — much lower than their general population June 17th, 2022 Spanish-speaking patients show strong interest in clinical trial participation in the US. For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result in lower participation rates of non-English speakers, an unsatisfactory patient experience and, ultimately, imprecise data. In the US, the leading country in clinical trial participation each year, language barriers May 28th, 2022 Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic. At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was March 31st, 2022 Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression. In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes March 14th, 2022 SubjectWell expands its proven marketplace to include non-small cell lung cancer trials SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to January 4th, 2022 Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology. Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
May 30th, 2024 3 in 4 surveyed patients show strong interest in replacing medications with both approved and experimental treatments. Over 131 million people in the US — roughly 66% of Americans — take prescription drugs regularly. That’s more than the number of people who watched the Super Bowl this year. And yet, 1 in 3 surveyed patients who take prescription medications said that they were unsatisfied with at least one of their current drugs. September 8th, 2023 Why HCP Outreach is so Important For Recruiting Patients in Rare Disease When it comes to recruiting patients for clinical trials in rare diseases, HCP outreach and support is essential. Most trials in the rare disease space struggle with patient recruitment unless they have a well thought out strategy on how to include HCPs in the recruitment process. December 7th, 2022 Compensation norms create inequity in clinical trials. Imagine a patient participating in a clinical trial for a new vaccine. They take a half day of PTO to visit the clinic, which is a short 15-minute drive from their home. After an hour visit, they are given $50 as compensation – a reasonable amount which they spend on a nice dinner. This describes November 8th, 2022 Secondary conditions and race/ethnicity affect type 2 diabetes patients’ interest in clinical trial participation. SubjectWell recently fielded a survey engaging over 300 type 2 diabetes patients. The findings showed that diabetes patients demonstrated high overall interest in clinical trial participation, but secondary conditions caused by their diabetes can shift that interest higher or lower. According to the CDC, more than 33 million Americans have type 2 diabetes. As patients’ September 8th, 2022 Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest. Minority populations are significantly underrepresented in clinical research. When comparing the FDA’s recent Drug Trial Snapshots data with US Census data, women, white patients, and older patients are shown to be overrepresented in clinical trials. Black patients make up just 8% and Hispanic patients 11% of trial participants — much lower than their general population June 17th, 2022 Spanish-speaking patients show strong interest in clinical trial participation in the US. For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result in lower participation rates of non-English speakers, an unsatisfactory patient experience and, ultimately, imprecise data. In the US, the leading country in clinical trial participation each year, language barriers May 28th, 2022 Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic. At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was March 31st, 2022 Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression. In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes March 14th, 2022 SubjectWell expands its proven marketplace to include non-small cell lung cancer trials SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to January 4th, 2022 Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology. Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
September 8th, 2023 Why HCP Outreach is so Important For Recruiting Patients in Rare Disease When it comes to recruiting patients for clinical trials in rare diseases, HCP outreach and support is essential. Most trials in the rare disease space struggle with patient recruitment unless they have a well thought out strategy on how to include HCPs in the recruitment process. December 7th, 2022 Compensation norms create inequity in clinical trials. Imagine a patient participating in a clinical trial for a new vaccine. They take a half day of PTO to visit the clinic, which is a short 15-minute drive from their home. After an hour visit, they are given $50 as compensation – a reasonable amount which they spend on a nice dinner. This describes November 8th, 2022 Secondary conditions and race/ethnicity affect type 2 diabetes patients’ interest in clinical trial participation. SubjectWell recently fielded a survey engaging over 300 type 2 diabetes patients. The findings showed that diabetes patients demonstrated high overall interest in clinical trial participation, but secondary conditions caused by their diabetes can shift that interest higher or lower. According to the CDC, more than 33 million Americans have type 2 diabetes. As patients’ September 8th, 2022 Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest. Minority populations are significantly underrepresented in clinical research. When comparing the FDA’s recent Drug Trial Snapshots data with US Census data, women, white patients, and older patients are shown to be overrepresented in clinical trials. Black patients make up just 8% and Hispanic patients 11% of trial participants — much lower than their general population June 17th, 2022 Spanish-speaking patients show strong interest in clinical trial participation in the US. For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result in lower participation rates of non-English speakers, an unsatisfactory patient experience and, ultimately, imprecise data. In the US, the leading country in clinical trial participation each year, language barriers May 28th, 2022 Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic. At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was March 31st, 2022 Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression. In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes March 14th, 2022 SubjectWell expands its proven marketplace to include non-small cell lung cancer trials SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to January 4th, 2022 Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology. Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
December 7th, 2022 Compensation norms create inequity in clinical trials. Imagine a patient participating in a clinical trial for a new vaccine. They take a half day of PTO to visit the clinic, which is a short 15-minute drive from their home. After an hour visit, they are given $50 as compensation – a reasonable amount which they spend on a nice dinner. This describes November 8th, 2022 Secondary conditions and race/ethnicity affect type 2 diabetes patients’ interest in clinical trial participation. SubjectWell recently fielded a survey engaging over 300 type 2 diabetes patients. The findings showed that diabetes patients demonstrated high overall interest in clinical trial participation, but secondary conditions caused by their diabetes can shift that interest higher or lower. According to the CDC, more than 33 million Americans have type 2 diabetes. As patients’ September 8th, 2022 Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest. Minority populations are significantly underrepresented in clinical research. When comparing the FDA’s recent Drug Trial Snapshots data with US Census data, women, white patients, and older patients are shown to be overrepresented in clinical trials. Black patients make up just 8% and Hispanic patients 11% of trial participants — much lower than their general population June 17th, 2022 Spanish-speaking patients show strong interest in clinical trial participation in the US. For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result in lower participation rates of non-English speakers, an unsatisfactory patient experience and, ultimately, imprecise data. In the US, the leading country in clinical trial participation each year, language barriers May 28th, 2022 Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic. At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was March 31st, 2022 Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression. In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes March 14th, 2022 SubjectWell expands its proven marketplace to include non-small cell lung cancer trials SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to January 4th, 2022 Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology. Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
November 8th, 2022 Secondary conditions and race/ethnicity affect type 2 diabetes patients’ interest in clinical trial participation. SubjectWell recently fielded a survey engaging over 300 type 2 diabetes patients. The findings showed that diabetes patients demonstrated high overall interest in clinical trial participation, but secondary conditions caused by their diabetes can shift that interest higher or lower. According to the CDC, more than 33 million Americans have type 2 diabetes. As patients’ September 8th, 2022 Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest. Minority populations are significantly underrepresented in clinical research. When comparing the FDA’s recent Drug Trial Snapshots data with US Census data, women, white patients, and older patients are shown to be overrepresented in clinical trials. Black patients make up just 8% and Hispanic patients 11% of trial participants — much lower than their general population June 17th, 2022 Spanish-speaking patients show strong interest in clinical trial participation in the US. For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result in lower participation rates of non-English speakers, an unsatisfactory patient experience and, ultimately, imprecise data. In the US, the leading country in clinical trial participation each year, language barriers May 28th, 2022 Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic. At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was March 31st, 2022 Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression. In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes March 14th, 2022 SubjectWell expands its proven marketplace to include non-small cell lung cancer trials SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to January 4th, 2022 Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology. Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
September 8th, 2022 Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest. Minority populations are significantly underrepresented in clinical research. When comparing the FDA’s recent Drug Trial Snapshots data with US Census data, women, white patients, and older patients are shown to be overrepresented in clinical trials. Black patients make up just 8% and Hispanic patients 11% of trial participants — much lower than their general population June 17th, 2022 Spanish-speaking patients show strong interest in clinical trial participation in the US. For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result in lower participation rates of non-English speakers, an unsatisfactory patient experience and, ultimately, imprecise data. In the US, the leading country in clinical trial participation each year, language barriers May 28th, 2022 Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic. At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was March 31st, 2022 Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression. In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes March 14th, 2022 SubjectWell expands its proven marketplace to include non-small cell lung cancer trials SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to January 4th, 2022 Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology. Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
June 17th, 2022 Spanish-speaking patients show strong interest in clinical trial participation in the US. For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result in lower participation rates of non-English speakers, an unsatisfactory patient experience and, ultimately, imprecise data. In the US, the leading country in clinical trial participation each year, language barriers May 28th, 2022 Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic. At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was March 31st, 2022 Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression. In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes March 14th, 2022 SubjectWell expands its proven marketplace to include non-small cell lung cancer trials SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to January 4th, 2022 Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology. Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
May 28th, 2022 Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic. At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was March 31st, 2022 Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression. In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes March 14th, 2022 SubjectWell expands its proven marketplace to include non-small cell lung cancer trials SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to January 4th, 2022 Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology. Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
March 31st, 2022 Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression. In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is by far the leading cause of cancer death, and more specifically, the vast majority of lung cancer diagnoses are NSCLC. To develop a better understanding of NSCLC patients’ attitudes March 14th, 2022 SubjectWell expands its proven marketplace to include non-small cell lung cancer trials SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to January 4th, 2022 Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology. Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
March 14th, 2022 SubjectWell expands its proven marketplace to include non-small cell lung cancer trials SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to January 4th, 2022 Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology. Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
January 4th, 2022 Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology. Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
September 10th, 2021 Survey of asthma patients found subgroup with limited acceptance of diagnosis. In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
July 6th, 2021 Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation. In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
June 21st, 2021 International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation. Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic, local HCPs informing and guiding patients on proper treatment and preventive measures were more successful than similar messages pushed from government agencies or medical institutions. However, while patient trust April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
April 14th, 2021 The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate their adoption. The major advantages of DCTs – untethered recruiting from physical site locations, patient-centric accommodations, integration of modern technology – all drastically affect the role of sites in April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
April 5th, 2021 Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available. Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically, people are clearly seeing how clinical trials have led to bringing the current coronavirus vaccines to market, now with more than 118 million doses administered in the US alone. January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
January 5th, 2021 As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research. Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD) can also lead to nonalcoholic steatohepatitis (NASH). Together, FLD and NASH impact the lives of more than 100 million Americans. And NASH is on the rise: by 2030, prevalent November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
November 13th, 2020 Concerns around clinical trial participation continue to differ by race. Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably the most critical time for clinical trial participation as COVID-19 cases continue to rise worldwide and vaccines and treatments are still being tested. By understanding what prevents or encourages July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
July 21st, 2020 Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic. At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of the pandemic. Having a grasp on these sentiments may now be more important than ever, as states continue the reopening process while positive cases continue to increase. Our most April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
April 17th, 2020 A growing number of patients are considering clinical trials as the coronavirus pandemic continues. In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to bringing novel treatments to market, SubjectWell completed the second of our recent insight surveys. We previously fielded surveys between March 19 and 23, 2020, to patients and sites throughout March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
March 26th, 2020 Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic. The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations, March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
March 25th, 2020 How to Boost Diversity in Clinical Trial Patient Recruitment Enrolling a diverse pool of patients is often a challenge for sponsors and CROs. Fortunately, digital patient outreach can help boost clinical trial recruitment efforts. March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
March 18th, 2020 Better Recruiting Practices for Rare Disease Clinical Trials Rare disease clinical trials come with a unique set of challenges. However, there are a few strategies that sponsors and CROs can use to boost patient recruitment and retention. February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
February 26th, 2020 How to Navigate Google’s Crackdown on Clinical Trial Scams Google is taking steps to ensure that users only see ads for reputable clinical trials. Here’s how sponsors and CROs can navigate these new policies. February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts
February 19th, 2020 A Guide to Patient Outreach for Heart Disease Clinical Trials In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials. « Previous Posts
